URINE FOR PORPHOBILINOGEN

In the context of Hypro Diagnostics, assessing porphobilinogen (PBG) levels in urine becomes pivotal for detecting and managing porphyria, a rare genetic disorder impacting the nervous system and skin. Typically, PBG excretion remains below 8.8 µmol/L in normal conditions. However, a significant elevation to 25 µmol/L or above suggests the potential presence of porphyria-related diseases. During porphyria attacks, the urgency intensifies as urine PBG levels surpass 100 µmol/L. Vigilant monitoring of these levels not only aids in early detection but also facilitates effective intervention and improved patient outcomes, aligning with Hypro Diagnostics’ commitment to diagnostic precision.